✦ LIBER ✦

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer

✍ Scribed by James J. Dignam; Kelly Wieand; Karen A. Johnson; Peter Raich; Stewart J. Anderson; Carol Somkin; D. Lawrence Wickerham

Publisher: Springer US
Year: 2005
Tongue: English
Weight: 360 KB
Volume: 97
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-005-9118-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Laminin receptors, collagenase IV and pr

Laminin receptors, collagenase IV and prognosis in node-negative breast cancers

✍ Maria Grazia Daidone; Rosella Silvestrini; Antonia D'Errico; Giovanni Di Fronzo; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 430 KB

In 187 node-negative breast cancers, the expression of laminin receptors and collagenase IV was directly related in 52% of cases, independently of pathological (tumor size and histology) and biological (estrogen receptors and proliferative activity) features. Moreover, the presence of laminin recept

Second thoughts on sentinel lymph node b

Second thoughts on sentinel lymph node biopsy in node-negative breast cancer

✍ G. P. Kuijt; R. M. H. Roumen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 1 views

Not quite as safe as was thought

Overexpression of cyclinD1 predicts for

Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients

✍ Yoshihisa Umekita; Yasuyo Ohi; Yoshiatsu Sagara; Hiroki Yoshida 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 94 KB

## Abstract CyclinD1 plays a critical role in regulating cell cycle progression. CyclinD1 mRNA and protein are overexpressed in approximately 50% of primary breast cancer cases. However, its clinical significance as a predictive factor remains unclear. One hundred and seventy‐three female patients

High genomic grade index associated with

High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy

✍ Yasuto Naoi; Kazuki Kishi; Tomonori Tanei; Ryo Tsunashima; Naoomi Tominaga; Yosu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB

DNA hypermethylation ofPITX2is a marker

DNA hypermethylation ofPITX2is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients

✍ Inko Nimmrich; Anieta M. Sieuwerts; Marion E. Meijer-van Gelder; Ina Schwope; Jo 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 279 KB

Hazard of recurrence and adjuvant treatm

Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer

✍ James J. Dignam; Vanja Dukic; Stewart J. Anderson; Eleftherios P. Mamounas; D. L 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 296 KB